Education
About Us
Working with TipRanks
Follow Us
Akari Therapeutics PLC (ADR) (AKTX)
:AKTX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | $ -19.20K |
| Operating Income | $ -16.81M | $ -23.09M | $ -17.21M | $ -17.98M | $ -24.87M |
| EBITDA | $ -16.80M | $ -23.08M | $ -17.21M | $ -20.44M | $ -24.73M |
| Net Income | $ -10.01M | $ -6.97M | $ -17.61M | $ -17.60M | $ -21.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.85M | $ 13.25M | $ 9.36M | $ 14.06M | $ 5.73M |
| Total Assets | $ 4.36M | $ 13.83M | $ 11.65M | $ 17.59M | $ 10.31M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.85M | $ -13.25M | $ -9.36M | $ -14.06M | $ -5.73M |
| Total Liabilities | $ 4.58M | $ 12.04M | $ 6.09M | $ 5.22M | $ 6.47M |
| Stockholders' Equity | $ -229.00K | $ 1.79M | $ 5.55M | $ 12.38M | $ 3.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.43M | $ -21.50M | $ -18.85M | $ -16.95M | $ -12.26M |
| Operating Cash Flow | $ -16.43M | $ -21.50M | $ -18.85M | $ -16.95M | $ -12.26M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 7.02M | $ 25.29M | $ 14.29M | $ 25.07M | $ 11.99M |
Akari Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.